MedTrace Logo

Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis

NCT02939950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 816

Last updated 2019-12-23

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the safety and effectiveness of the Bausch + Lomb samfilcon A soft (hydrophilic) contact lens, a new silicone hydrogel contact lens, compared to the Bausch + Lomb PureVision® soft contact lens when worn for 7-day extended wear by adapted soft contact lens wearers.

Conditions

  • Myopia

Interventions

DEVICE

Bausch + Lomb Samfilcon A Soft Contact Lens

soft contact lenses

DEVICE

Bausch + Lomb Pure Vision Soft Contact Lens

soft contact lenses

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson Varughese · Bausch Health Americas, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-08-03
Completion
2016-08-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02939950 on ClinicalTrials.gov